Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 834

Results For "MP"

9962 News Found

Mental healthcare app heyy raises pre-seed funding
Startup | February 22, 2022

Mental healthcare app heyy raises pre-seed funding

US $ 555,000 invested by Wavemaker Partners in pre-seed round


Velocity Clinical Research invests in Indian tech, acquires TrierHealth
Biotech | February 22, 2022

Velocity Clinical Research invests in Indian tech, acquires TrierHealth

The investment in Indian clinical technology expertise in Hyderabad comes amid the clinical trials sector's move towards decentralised trials


Asahi Kasei to build new production unit for membrane virus filters in Japan
News | February 22, 2022

Asahi Kasei to build new production unit for membrane virus filters in Japan

The COVID-19 pandemic has triggered the rapid growth of the biotherapeutics market


IFF to acquire contract manufacturer of dietary supplements Health Wright Products
News | February 22, 2022

IFF to acquire contract manufacturer of dietary supplements Health Wright Products

The sale is expected to close in the first quarter of 2022


Dow, Sartorius and Südpack collaborate to support global supply of coronavirus vaccines
News | February 22, 2022

Dow, Sartorius and Südpack collaborate to support global supply of coronavirus vaccines

Essential products manufactured by Sartorius, using Sü dpack polymer films made from Dow resins, support safe and effective vaccine production for global vaccine supply


CanSinoBIO's Convidecia approved as heterologous booster in China
News | February 21, 2022

CanSinoBIO's Convidecia approved as heterologous booster in China

Heterologous booster vaccination refers to the use of vaccine boosters from different technology platforms from the prime vaccines, which could improve the overall immune response and enhance protection against other variants


Binnopharm acquires two anti-bacterial brands from Dr. Reddy’s
Biotech | February 21, 2022

Binnopharm acquires two anti-bacterial brands from Dr. Reddy’s

Dr. Reddy’s, will focus its resources and capabilities on its key therapy spaces of gastroenterology, pain management, cold and flu, allergy, oncology, neurology, paediatrics and women’s health as the Russia and CIS region continues to be a strong performer for the company


SEBI approves IPO plans of PharmEasy and Wellness Forever Medicare
News | February 21, 2022

SEBI approves IPO plans of PharmEasy and Wellness Forever Medicare

The companies plan to use the proceeds to retire debt and expand operations


Strides receives USFDA approval for Amantadine Hydrochloride capsules
Drug Approval | February 21, 2022

Strides receives USFDA approval for Amantadine Hydrochloride capsules

To be marketed by Strides Pharma Inc. in the US market


IIT Delhi develops strategy for development of drug molecules
Biotech | February 21, 2022

IIT Delhi develops strategy for development of drug molecules

The researchers are of the view that the new drug designing strategy demonstrated by them could also be adopted to treat retroviral infections.